Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Britto, Anna V ^a   Schenka, André A ^a   Moraes Schenka, Natália G ^a   Alvarenga, Marcelo ^a   Shinzato, Júlia Y ^a   Vassallo, José ^a   Ward, Laura S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; PROTEIN; PROTEIN D2-40; UNCLASSIFIED DRUG; VASCULOTROPIN A; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40; PDPN PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROVASCULATURE; PROTEIN EXPRESSION; RISK ASSESSMENT; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR VASCULARIZATION; VASCULAR TUMOR; BREAST TUMOR; IMMUNOLOGY; LYMPHANGIOGENESIS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PREDICTION AND FORECASTING; RISK FACTOR; STATISTICAL MODEL; VASCULARIZATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 65149097852     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-109     Document Type: Article

References (47)

1. Adjuvant Breast Cancer Trials Collaborative Group Polychemotherapy for early breast cancer: Results from the International Adjuvant Breast cancer Chemotherapy Randomized Trial J Natl Cancer Inst 2007, 99:506-515. 17405995
2. Gasparini G Clinical significance of determination of surrogate markers of angiogenesis in breast cancer Crit Rev Oncol Hematol 2001, 37:97-114. 11166583
3. Weidner N Semple JP Welch WR Folkman J Tumor angiogenesis and metastasis-correlation in invasive breast cancer N Engl J Med 1991, 324:1-8. 1701519
4. Ogawa Y Chung YS Nakata B Takatsuba S Maeda K Sawada T Kato Y Yoshikawa K Sakurai M Sowa M Microvessel quantification in invasive breast cancer by staining for factor VIII-related antigen Br J Cancer 1995, 71:297-301.
5. Simpson JF Ahn C Battifora H Esteban JM Endothelial area as a prognostic indicator for invasive breast carcinoma Cancer 1996, 77:2077-2085. 8640673
6. Martin L Green B Renshaw C Lowe D Rudland P Leinster SJ Winstanley J Examining the technique of angiogenesis assessment in invasive breast cancer Br J Cancer 1997, 76:1046-1054. 9376265
7. Gasparini G Toi M Verderio P Ranieri G Dante S Bonoldi E Boracchi P Fanelli M Tominaga T Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: Subanalysis in node-positive and node-negative patients Int J Oncol 1998, 12:1117-11125. 9538138
8. De Placido S Carlomagno C Ciardello F de Laurentiis M Pepe S Ruggiero A Tortora G Panico L D'Antonio A Pettinato G Petrella G Bianco AR Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up Clin Cancer Res 1999, 5:2854-2859. 10537353
9. Kumar S Ghellal A Li C Byrne G Haboubi N Wang JM Bundred N Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis Cancer Res 1999, 59:856-61. 10029075
10. Hansen S Grabau DA Sorensen FB Bak M Vach W Rose C Vascular grading of angiogenesis: peognostic significance in breast cancer Br J Cancer 2000, 82:339-347. 10646886
11. Tsutsui S Kume M Era S Prognostic value of microvessel density in invasive ductal carcinoma of the breast Breast Cancer 2003, 10:312-319. 14634509
12. Schoppmann FS Bayer G Aumayer K Taucher S Geleff S Rudas M Kubista E Hausmaninger H Samonigg H Gnant M Jakesz R Horvat R Austrian Breast and Colorectal Cancer Study Group Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer Annals Surg 2004, 240:306-312.
13. Nakamura Y Yasuoka H Tsujimoto M Imabun S Nakahara M Nakao K Nakamura M Mori I Kakudo K Lymph vessel density correlates with nodal status, VEGF-A-C, expression and prognosis in breast cancer Breast Cancer Res Treat 2005, 91:125-132. 15868440
14. Mohammed RA Green A El-Shikh S Paish EC Ellis IO Martin SG Prognostic significance of vascular endothelial cell growth factors-A, C and D in breast cancer and their relationship with angio and lymphangiogenesis Br J Cancer 2007, 96:1092-1100. 17353919
15. Uzzan B Nicolas P Cucherat M Perret GY Microvessel density as a prognostic factor in women with breast cancer: A systematic review of the literature and meta-analysis Cancer Res 2004, 64:2941-2955. 15126324
16. Goldhirsch A Glick JH Gelber RD Coates AS Thurlimann B Senn HJ Panel members Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 2005, 16:1569-1583. 16148022
17. Marinho VF Metze K Sanches FS Rocha GF Gobbi H Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis BMC Cancer 2008, 8:64. 2294134 18307818
18. Greene FL Page DL Fleming ID Fritz AG Balch CM Haller DG Morrow M Breast AJCC Cancer Staging Manual New York: Springer Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M 6 2002:223-240.
19. Elston CW Ellis IO Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up Histopathology 1991, 19:403-410. 1757079
20. Cserni G Evaluation of sentinel lymph nodes in breast cancer Histopathology 2005, 46:697-706. 15910602
21. Harvey JM Clark GM Osborne K Allred DC Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J Clin Oncol 1999, 17:1474-1481. 10334533
22. Yaziji H Taylor CR Begin at the beginning, with the tissue! The key message underlying the ASCO/CAP Task-force Guideline Recommendations for HER2 testing Appl Immunohistochem Mol Morphol 2007, 15:239-241. 17721265
23. Tanner M Gancberg D Di Leo A Larsimont D Rouas G Piccart MJ Isola J Chromogenic in situ Hybridization. A practical alternative for fluorescence in situ hibridization to detect HER-2/neu oncogene amplification in archival breast cancer samples Am J Pathol 2000, 157:1467-72. 1885742 11073807
24. Yamauchi C Hasebe T Iwasaki M Imoto S Wada N Fukayama M Ochiai A Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance Hum Pathol 2007, 38:247-259. 17056095
25. Carter CL Allen C Henson DE Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases Cancer 1989, 63:181-187. 2910416
26. Rivadeneira DE Simmons RM Christos PJ Hanna K Daly JM Osborne MP Predictive Factors associated with Axillary Lymph Node Metastases in T1a and T1b Breast Carcinomas: Analysis in More Than 900 Patients J Am Coll Surg 2000, 191:1-6. 10898177
27. Arnaout-Alkarain A Kahn HJ Narod SA Sun PA Marks AN Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer Mod Pathol 2007, 20:183-191. 17206106
28. Braun M Flucke U Debald M Walgenbach-Bruenagel G Walgenbach K-J Holler T Polcher M Wolfgarten M Sauerwald A Keyver-Paik M Kuehr M Buttner R Kuhn W Detection of lymphovascular invasion in early breast cancer by D2-40(podoplanin): A clinically useful predictor for axillary lymph node metastasis Breast Cancer Res Treat 2008, 112(3):503-511. 18165897
29. Tezuka K Onoda N Takashima T Takagaki K Ishikawa T Wakasa T Wakasa K Hirakawa K Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients Oncol Rep 2007, 17:997-1003. 17390035
30. El-Gohary YM Metwally G Saad RS Robinson MJ Mesko T Poppiti RJ Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas Am J Clin Pathol 2008, 129:578-586. 18343785
31. Ito M Moriya T Ishida T Usami S Kasajima A Sasano H Ohuchi N Significance of Pathological Evaluation for Lymphatic Vessel Invasion in Invasive Breast Cancer Breast Cancer 2007, 14:381-387. 17986803
32. Chagpar AB Scoggins CR Martin RC 2nd Carlson DJ Laidley AL El-Eid SE McGlothin TQ Prediction of sentinel lymph node-only disease in women with invasive breast cancer Am J Surg 2006, 192:882-887. 17161113
33. Leidenius MHK Vironen JH Riihelä MS Krogerus LA Toivonen TS von Smitten KAJ Heikkilä PS The prevalence of non-sentinel node metastasis in breast cancer patients with sentinel node micrometastasis EJSO 2005, 31:13-18. 15642420
34. Choi SH Barsky SH Chang HR Clinicopathologic Analysis of Sentinel Lymph Node mapping in early breast cancer Breast J 2003, 9:153-162. 12752622
35. Viale G Zurrida S Maiorano E Mazzarol G Pruneri G Paganelli G Maisonneuve P Veronesi U Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution Cancer 2005, 103:492-500. 15612028
36. Colleoni M Rotmensz N Maisonneuve P Sonzogni A Pruneri G Casadio C Luini A Veronesi P Intra M Galimberti V Torrisi R Andrighetto S Ghisini R Goldhirschi A Viale G Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer Annals of Oncology 2007, 18:1632-1640. 17716986
37. Bono P Wasenius V-M Heikkila P Lundin J Jackson DG Joensuu H High LYVE-1-Positive Lymphatic Vessel Numbers Are Associated with Poor Outcome in Breast Cancer Clinical Cancer Research 2004, 10:7144-7149. 15534085
38. Rabban JT Chen YY D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma Human Pathology 2008, 39:175-183. 18206495
39. Auwera Van der I Cao Y Tille JC Pepper MS Jackson DG Fox SB Harris AL Dirix LY Vermeulen PB First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours Br J Cancer 2006, 95:1611-1625. 17117184
40. Gasparini G Prognostic value of vascular endothelial growth factor in breast cancer Oncologist 2000, 5(Suppl 1):37-44. 10804090
41. Fridman V Humblet C Bonjean K Boniver J Assessment of tumor angiogenesis in invasive breast carcinomas: Absence of correlation with prognosis and pathological factors Virchows Arch 2000, 437:611-617. 11193472
42. Ludovini V Sidoni A Pistola L Bellezza G de Angelis V Gori S Mosconi AM Bisagni G Cherubini R Bian AR Rodinò C Sabbatini R Mazzocchi B Bucciarelli E Tonato M Colozza M Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients Breast Cancer Res Treat 2003, 81:159-168. 14572158
43. Nicolini A Campani D Miccoli P Spinelli C Carpi A Menicagli M Ferrari P Gadducci G Rossi G Fini M Giavaresi G Bonazzi V Giardino R Vascular endothelial growth factor (VEGF-A) and other common tissue prognostic indicators in breast cancer: A case-control study Int J Biol Markers 2004, 19:275-281. 15646833
44. Mylona E Alexandrou P Mpakali A Giannopoulou I Liapis G Markaki S Keramopoulos A Nakopoulou L The prognostic value of vascular endothelial growth factors (VEGF-As)-A and B and their receptor, VEGF-AR-1, in invasive breast carcinoma Gynecol Oncol 2007, 104:557-563. 17150246
45. Evangelou E Kyzas PA Trikalinos TA Comparison of the diagnostic accuracy of lymphatic endothelial markers: Bayesian approach Mod Pathol 2005, 18:1490-1497. 15990898
46. Vermeulen PB Gasparini G Fox SB Fox SB Colpaert C Marson LP Gion M Belien JA de Waal RM Van Marck E Magnani E Weidner N Harris AL Dirix LY Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid tumours Eur J Cancer 2002, 38:1564-1579. 12142044
47. Weidner N Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors Breast Cancer Res Treat 1995, 36:169-180. 8534865